SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (2775)11/13/1997 11:58:00 PM
From: Oliver & Co  Read Replies (1) of 6136
 
Every patient has a certain # of mutant (resistant) viruses. It is imperative to EDUCATE, problems with adherance happen all the time in medicine. However, optimal education, and some training is necessary. The best patient is the informed patient, but in todays medicine, resources are scarcer every day, maybe they should have put in the guidelines that before you give a prescription to a patient, you, or your staff has to be sure the patient understands,and agrees with the treatment, and a "Dry Run" is performed.
These guidelines are geared , not to us Specialists, but to all those who aretrying to deal with the unknown. What do you think would happen to a cancer patient if they ended up with an Internist who will follow the guidelines, but not refer to an Oncologist?.

Thanks,

JLL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext